The UK pharmaceutical and life sciences sector is braced for a busier year in terms of mergers and acquisitions (M&A), following a quiet 2024, bot...
View articleForvis Mazars has announced a new Executive team to lead its UK operations, with five new appointments joining CEO James Gilbey’s leadership group. Th...
View article